stocks logo

ADVB

Advanced Biomed Inc
$
0.422
+0.004(0.956%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
0.470
Open
0.4167
VWAP
0.44
Vol
326.59K
Mkt Cap
9.13M
Low
0.41525
Amount
144.39K
EV/EBITDA(TTM)
--
Total Shares
21.64M
EV
3.87M
EV/OCF(TTM)
--
P/S(TTM)
--
Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.
Show More
AI Stock Picker

Valuation Metrics

The current forward P/E ratio for Advanced Biomed Inc (ADVB.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Advanced Biomed Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent

Financials

Annual
Quarterly
FY2025Q3
YoY :
+2.32%
-762.74K
Operating Profit
FY2025Q3
YoY :
+31.02%
-1.38M
Net Income after Tax
FY2025Q3
YoY :
+40.00%
-0.07
EPS - Diluted
FY2025Q3
YoY :
+221.03%
-3.42M
Free Cash Flow

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Intellectia AI SwingMax

ADVB News & Events

News

8.5
03-10Benzinga
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
Sign Up For More News

FAQ

arrow icon

What is Advanced Biomed Inc (ADVB) stock price today?

The current price of ADVB is 0.4221 USD — it has increased 0.96 % in the last trading day.

arrow icon

What is Advanced Biomed Inc (ADVB)'s business?

arrow icon

What is the price predicton of ADVB Stock?

arrow icon

What is Advanced Biomed Inc (ADVB)'s revenue for the last quarter?

arrow icon

What is Advanced Biomed Inc (ADVB)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Advanced Biomed Inc (ADVB)'s fundamentals?

arrow icon

How many employees does Advanced Biomed Inc (ADVB). have?

arrow icon

What is Advanced Biomed Inc (ADVB) market cap?